This is a multi-centre, randomised, controlled, investigator blinded study. The randomisation will be done centrally. The patients will be treated for 1 year, with clinical and laboratory assessments at 0, 4, 8 and 12 months. Endoscopic examination is at enrollment and on completion of the study (at relapse or after 12 months). Number of Subjects (Planned and Analysed): * 360 patients for demonstration of non-inferiority between once daily and twice daily; * 326 to be analysed in per-protocol (PP) analyses; and * 360 in intention-to-treat (ITT) analyses.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
362
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
UMC Sint-Pieter
Brussels, Belgium
Hôpital Erasme Unité de Recherche, Clinique Gastro-entérologie
Brussels, Belgium
UZ Gent
Ghent, Belgium
UZ Gasthuisberg
Leuven, Belgium
CHR de la Citadelle
Liège, Belgium
Heilig Hart Ziekenhuis
Roeselaere, Belgium
AZ St. Augustinus
Wilrijk, Belgium
Internal department Hospital Tábor
Jaroše, Czechia
Internal department, Hospital Jičín
Jičín, Czechia
Internal department Hospital Chomutov
Kochova, Czechia
...and 59 more locations